FR2333501A2 - Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant - Google Patents

Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Info

Publication number
FR2333501A2
FR2333501A2 FR7536918A FR7536918A FR2333501A2 FR 2333501 A2 FR2333501 A2 FR 2333501A2 FR 7536918 A FR7536918 A FR 7536918A FR 7536918 A FR7536918 A FR 7536918A FR 2333501 A2 FR2333501 A2 FR 2333501A2
Authority
FR
France
Prior art keywords
obtaining
new
methods
pharmaceutical compositions
acetamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7536918A
Other languages
English (en)
Other versions
FR2333501B2 (fr
Inventor
Michel Vincent
Georges Remond
Michel Laubie
Jean-Claude Poignant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Priority to FR7536918A priority Critical patent/FR2333501A2/fr
Priority to IL51016A priority patent/IL51016A/xx
Priority to US05/745,032 priority patent/US4123531A/en
Priority to NL7613469A priority patent/NL7613469A/xx
Priority to BE172929A priority patent/BE849013A/fr
Priority to ES453927A priority patent/ES453927A1/es
Priority to JP14550476A priority patent/JPS5283355A/ja
Priority to DE19762654888 priority patent/DE2654888A1/de
Priority to GB50528/76A priority patent/GB1560839A/en
Priority to CH1527176A priority patent/CH609965A5/xx
Publication of FR2333501A2 publication Critical patent/FR2333501A2/fr
Application granted granted Critical
Publication of FR2333501B2 publication Critical patent/FR2333501B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7536918A 1975-12-03 1975-12-03 Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant Granted FR2333501A2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR7536918A FR2333501A2 (fr) 1975-12-03 1975-12-03 Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
US05/745,032 US4123531A (en) 1975-12-03 1976-11-26 Anti-convulsant N-ethanolamine diphenyl acetamides
IL51016A IL51016A (en) 1975-12-03 1976-11-26 Substituted n (aminoalkyl) diphenylacetamides their production and pharmaceutical compositions containing them
BE172929A BE849013A (fr) 1975-12-03 1976-12-02 Nouveaux diphenylacetamides, leur procede d'obtention et leur emploi comme medicament
NL7613469A NL7613469A (nl) 1975-12-03 1976-12-02 Werkwijze voor de bereiding van geneesmiddelen met klonische krampen opheffende werking, dergelijke geneesmiddelen en werkwijze voor de bereiding van de werkzame verbindingen.
ES453927A ES453927A1 (es) 1975-12-03 1976-12-03 Un procedimiento de obtencion de nuevas difenilacetamidas.
JP14550476A JPS5283355A (en) 1975-12-03 1976-12-03 Diphenylacetoamides
DE19762654888 DE2654888A1 (de) 1975-12-03 1976-12-03 Diphenylacetamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
GB50528/76A GB1560839A (en) 1975-12-03 1976-12-03 X,x-diphenyl acetamides process for their production and pharmaceutical compositions containing them
CH1527176A CH609965A5 (fr) 1975-12-03 1976-12-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7536918A FR2333501A2 (fr) 1975-12-03 1975-12-03 Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Publications (2)

Publication Number Publication Date
FR2333501A2 true FR2333501A2 (fr) 1977-07-01
FR2333501B2 FR2333501B2 (fr) 1978-08-25

Family

ID=9163236

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7536918A Granted FR2333501A2 (fr) 1975-12-03 1975-12-03 Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Country Status (10)

Country Link
US (1) US4123531A (fr)
JP (1) JPS5283355A (fr)
BE (1) BE849013A (fr)
CH (1) CH609965A5 (fr)
DE (1) DE2654888A1 (fr)
ES (1) ES453927A1 (fr)
FR (1) FR2333501A2 (fr)
GB (1) GB1560839A (fr)
IL (1) IL51016A (fr)
NL (1) NL7613469A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0367040A1 (fr) * 1988-11-04 1990-05-09 Kabi Pharmacia AB Composés pour le traitement de l'incontinence d'urine
US5236956A (en) * 1988-11-04 1993-08-17 Kabi Pharmacia Aktiebolag Compounds for the treatment of urinary incontinence

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53119059U (fr) * 1977-03-01 1978-09-21
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof
US5192779A (en) * 1989-02-14 1993-03-09 Fujisawa Pharmaceutical Co., Ltd. Substituted-acetamide compound and a process for the preparation thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2634274A (en) * 1951-03-10 1953-04-07 Searle & Co Basically substituted n-alkyl derivatives of alpha, alpha-ditolylpropion-amide and salts thereof
GB1170274A (en) 1966-09-16 1969-11-12 Koninklijke Pharma Fab Nv Benzhydryl or Dibenzocycloheptenyl Aminopropanol Ethers
BE791818A (fr) 1971-11-24 1973-05-23 Koninklijke Pharma Fab Nv Ethers diphenylmethylaminopropyliques therapeutiquement utiles
FR2176473B1 (fr) 1972-03-20 1975-03-14 Innothera Lab Sa

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, VOL. 59, 12604-5 1963 CITE: ZH OBSHCH KHIM, VOL. 33 PAGES 1570-3 1963 ) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0367040A1 (fr) * 1988-11-04 1990-05-09 Kabi Pharmacia AB Composés pour le traitement de l'incontinence d'urine
US5236956A (en) * 1988-11-04 1993-08-17 Kabi Pharmacia Aktiebolag Compounds for the treatment of urinary incontinence

Also Published As

Publication number Publication date
FR2333501B2 (fr) 1978-08-25
JPS5283355A (en) 1977-07-12
IL51016A (en) 1979-12-30
BE849013A (fr) 1977-06-02
GB1560839A (en) 1980-02-13
IL51016A0 (en) 1977-01-31
ES453927A1 (es) 1977-11-01
US4123531A (en) 1978-10-31
CH609965A5 (fr) 1979-03-30
NL7613469A (nl) 1977-06-07
DE2654888A1 (de) 1977-06-08

Similar Documents

Publication Publication Date Title
BE842329A (fr) Nouveaux esters-17b d'oestradiol et compositions therapeutiques renfermant des esters-17b d'oestradiol
FR2278335A1 (fr) Derives d'azetidinones et leurs procedes de preparation
FR2301497A1 (fr) Composition d'engrais
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
FR2326920A1 (fr) Composes d'azetidinone et procedes pour leur preparation
BE861359A (fr) Aliments pour animaux contenant de l'acide folique et leurs procedes de preparation
BE818431A (fr) Nouveaux pseudotrisaccharides et leurs procedes d'obtention
BE846081A (fr) Nouveaux derives d'amidoximes, leur preparation et compositions en contenant
FR2283686A1 (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant
BE871623A (fr) Nouveaux derives du tetrazole et compositions pharmaceutiques les contenant
BE854908A (fr) Nouvelles aryl trifluoroethylamines, procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2276364A1 (fr) Nouvelles compositions d'azido-silanes et leur procede d'application
BE848962A (fr) Nouveaux derives de l'indazole
FR2343730A1 (fr) Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant
BE848227A (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant,
FR2302102A1 (fr) Nouvelles substances antibiotiques derivees de l'antibiotique 67-694 et leurs procedes de preparation
FR2333501A2 (fr) Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
BE839187A (fr) Derives d'histidine, procedes pour leur preparation et compositions therapeutiques contenant ces composes
PT65164B (fr) Procede pour la preparation de nouveaux benzamides substitues et leurs derives
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
FR2346355A1 (fr) Nouveaux amoxycillinates d'amidinopenicillanoyloxyalkyle et leurs procedes de preparation
FR2313027A1 (fr) Nouveaux anilides leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
BE828633A (fr) Nouveaux indazoles, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
BE870801A (fr) Nouveaux thiopropionamides, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2319351A1 (fr) Hydantoines et procedes d'obtention